SWHR convened an interdisciplinary Alzheimer’s Disease Policy Working Group of policy experts, researchers, clinicians, and patient advocates for a closed, roundtable meeting in August 2022 to discuss policy needs and opportunities as they relate to improving health and quality of life outcomes in Alzheimer’s disease and related dementias for women.
SWHR will oversee the Coalition to Advance Maternal Therapeutics (CAMT), a coalition founded in 2014 to increase inclusion of pregnant and lactating populations in clinical research.
A Call to Action from the Society for Women’s Health Research BACKGROUND Lupus is a chronic immune-mediated inflammatory disease in […]
During the July 26, 2022, “Taking Heed of Alzheimer’s Disease" briefing, disease stakeholders discussed research and treatment for AD and its disproportionate impact on women.
SWHR gathered psoriatic arthritis health care providers, researchers, patients and patient advocates in June 2022 to discuss the health, social, and economic impacts of PsA on women’s health across the lifespan.
SWHR convened an interdisciplinary Autoimmune Policy Working Group to discuss policy needs and opportunities as they relate to women’s autoimmune and immune-mediated diseases and conditions across the lifespan.
The rate of autoimmune diseases and conditions in the United States is rising—and women are disproportionately affected: 80% of patients […]
This June 2022 Working Group gathered clinicians, researchers, patients and patient advocates, and policy leaders for a discussion on gaps and opportunities in lupus care for women.